Scott Koenig's Email & Phone

Dr. Koenig has been President and Chief Executive Officer of MacroGenics since September 2001. Prior to joining MacroGenics, he served as Senior Vice President of Research at MedImmune Inc., where he participated in the selection and maturation of the company's product pipeline for 11 years. From 1984 to 1990, he worked in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health, where he investigated the immune response to retroviruses and studied the pathogenesis of AIDS. Currently, he is Chairman of the Board of Directors at Applied Genetic Therapy Corporation, a private venture-backed biotechnology company developing genetic therapies using adeno-associated virus vectors. Dr. Koenig is a Board member of BIO, as well as a member of its Emerging Companies Section Governing Body. Dr. Koenig is also a Board member of the Children's Research Institute at the Children's National Medical Center. Dr. Koenig received his A.B. and Ph.D. from Cornell University and his M.D. from the University of Texas Health Science Center in Houston, where he was elected to Alpha Omega Alpha. He completed his residency in Internal Medicine at the Hospital of the University of Pennsylvania and is Board certified in Internal Medicine and Allergy and Immunology.